InAER - Investigaciones en Alergia y Enfermedades Respiratorias - CABA, Buenos Aires
Somos un equipo interdisciplinario de especialistas con más de 20 años de experiencia en la investigación clínica y asistencial en el campo de las Enfermedades Respiratorias, particularmente en Alergia e Inmunología. Cubrimos toda la gama de afecciones respiratorias: asma, enfermedad pulmonar obstructiva crónica (EPOC), Rinitis, Rino-sinusitis, Poliposis Nasal, Sinusitis, y enfermedades alérgicas dermatológicas.Arenales 3146, CABA, Buenos Aires
Select an option
I am a doctor
I am a sponsor
Specializations
Neurodermatitis
Asma
EPOC Enfermedad pulmonar obstructiva crónica
Urticaria espontánea crónica
Our team
Medical staff
Anahi Yañez
Anahí Yañez
Norma Aramayo
Open studies
Asthma
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids - Umbriel - AstraZenecaSee more
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma - ARIA - GlaxoSmithKlineSee more
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS) - KALOS - AstraZenecaSee more
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma - Novartis PharmaceuticalsSee more
Prurigo nodularis
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1) - STOP-PN1 - Incyte CorporationSee more
Dermatitis
A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis - READY-AD - Janssen Research & Development, LLCSee more
Urticaria
24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up - CLOU064F12301 - Novartis PharmaceuticalsSee more
Chronic obstructive pulmonary disease
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease - THARROS - AstraZenecaSee more
